[HTML][HTML] Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities
P Toren, A Zoubeidi - International journal of oncology, 2014 - spandidos-publications.com
Abstract The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In
prostate cancer, the activation of this pathway appears to be characteristic of many …
prostate cancer, the activation of this pathway appears to be characteristic of many …
Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities
P Toren, A Zoubeidi - International journal of oncology, 2014 - pubmed.ncbi.nlm.nih.gov
The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In prostate
cancer, the activation of this pathway appears to be characteristic of many aggressive …
cancer, the activation of this pathway appears to be characteristic of many aggressive …
[HTML][HTML] Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities
P Toren, A Zoubeidi - International Journal of Oncology, 2014 - spandidos-publications.com
Abstract The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In
prostate cancer, the activation of this pathway appears to be characteristic of many …
prostate cancer, the activation of this pathway appears to be characteristic of many …
Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities
P Toren, A Zoubeidi - International Journal of Oncology, 2014 - europepmc.org
The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In prostate
cancer, the activation of this pathway appears to be characteristic of many aggressive …
cancer, the activation of this pathway appears to be characteristic of many aggressive …
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities
P TOREN, A ZOUBEIDI - INTERNATIONAL JOURNAL OF …, 2014 - ingentaconnect.com
The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In prostate
cancer, the activation of this pathway appears to be characteristic of many aggressive …
cancer, the activation of this pathway appears to be characteristic of many aggressive …
[引用][C] Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities
P TOREN, A ZOUBEIDI - International Journal of Oncology, 2014 - cir.nii.ac.jp
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review) |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities
P TOREN, A ZOUBEIDI - International Journal of Oncology, 2014 - search.proquest.com
Abstract The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In
prostate cancer, the activation of this pathway appears to be characteristic of many …
prostate cancer, the activation of this pathway appears to be characteristic of many …
[PDF][PDF] Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities
P TOREN, A ZOUBEIDI - INTERNATIONAL JOURNAL OF …, 2014 - scholar.archive.org
The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In prostate
cancer, the activation of this pathway appears to be characteristic of many aggressive …
cancer, the activation of this pathway appears to be characteristic of many aggressive …
Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities
P Toren, A Zoubeidi - International Journal of Oncology, 2014 - go.gale.com
The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In prostate
cancer, the activation of this pathway appears to be characteristic of many aggressive …
cancer, the activation of this pathway appears to be characteristic of many aggressive …